AI Article Synopsis

Article Abstract

Gastrointestinal and hepatobiliary malignancies in the pediatric age group are rare tumors and are usually treated with frustratingly poor results because of late diagnosis. Current efforts to improve treatment are directed at earlier diagnosis of these tumors in combination with aggressive surgery and adjuvant therapy.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0039-6109(16)43996-4DOI Listing

Publication Analysis

Top Keywords

gastrointestinal malignancies
4
malignancies infancy
4
infancy childhood
4
childhood adolescence
4
adolescence gastrointestinal
4
gastrointestinal hepatobiliary
4
hepatobiliary malignancies
4
malignancies pediatric
4
pediatric age
4
age group
4

Similar Publications

Purpose: Human epidermal growth factor receptor 2 (HER2)-targeted therapies have shown promise in treating -amplified metastatic colorectal cancer (mCRC). Identifying optimal biomarkers for treatment decisions remains challenging. This study explores the potential of artificial intelligence (AI) in predicting treatment responses to trastuzumab plus pertuzumab (TP) in patients with -amplified mCRC from the phase II TRIUMPH trial.

View Article and Find Full Text PDF

Background: The rising prevalence of depression among cancer patients is alarming. This study examines the relationship between the Oxidative Balance Score (OBS)-a composite measure of dietary and lifestyle factors-and depression, including specific depressive symptoms in this population.

Methods: Data were analyzed from 3,280 adult cancer patients collected in NHANES from 2005-2020.

View Article and Find Full Text PDF

Background: Lymphatic metastasis in gastric cancer (GC) profoundly influences its prognosis, but the precise mechanism remains elusive. In this study, we identified the long noncoding RNA MIR181A2HG as being upregulated in GC and associated with LNs metastasis and prognosis.

Methods: The expression of MIR181A2HG in GC was identified through bioinformatics screening analysis and qRT-PCR validation.

View Article and Find Full Text PDF

Background: Post-transplant lymphoproliferative disease (PTLD) is a significant complication that can arise following solid organ transplantation or hematopoietic stem cell transplantation. It encompasses a spectrum of lymphoproliferative lesions, ranging from benign reactive hyperplasia to malignant tumors, and is among the most severe complications following liver transplantation in children. It is essential for clinicians to gain a comprehensive understanding of the prevention, clinical manifestations, early diagnosis, and treatment strategies for PTLD in order to reduce mortality rates.

View Article and Find Full Text PDF

Current models for the study of neuroendocrine tumours (NETs) are severely limited. While (e.g.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!